ArticleCancer medicine2022

Progression-free survival at 3 years is a reliable surrogate for 5-year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma.

Yu-Xian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.